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Abstract 
Background: Current biological pathways to produce biofuel intermediates amenable to separations and catalytic 
upgrading to hydrocarbon fuels are not cost effective. Previously, oleaginous yeasts have been investigated primar-
ily for lipid production. However, yeasts store neutral lipids intracellularly making recovery difficult and expensive. In 
addition, once recovered from the cells, lipids are difficult to blend directly with the existing fuels without upgrading. 
We have, therefore, begun to investigate secreted fatty acid-derived products which can be easily recovered and 
upgraded to fuels.
Results: In this study, we successfully demonstrate the production of fatty alcohols by the oleaginous yeasts, Yar-
rowia lipolytica and Lipomyces starkeyi, through expression of the fatty acyl-CoA reductase gene from Marinobactor 
aquaeolei VT8. This strategy resulted in the production of 167 and 770 mg/L of fatty alcohols in shake flask from Y. 
lipolytica and L starkeyi, respectively. When using a dodecane overlay during fermentation, 92 and 99% of total fatty 
alcohols produced by Y. lipolytica and L. starkeyi, respectively, were extracted into the dodecane phase, which com-
pares favorably to the 3 and 50% recovered, respectively, without the dodecane layer. In both oleaginous yeasts, 
long chain length, saturated fatty alcohols, i.e., hexadecanol (C16:0) and octadecanol (C18:0), were predominant and 
accounted for more than 85% of the total fatty alcohols produced. To the best of our knowledge, this is the first report 
of fatty alcohol production in L. starkeyi.
Conclusion: This work demonstrates that the oleaginous yeasts, Y. lipolytica and L. starkeyi, can serve as platform 
organisms for the production of fatty acid-derived biofuels and bioproducts.
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Background
Oleaginous yeasts have received increasing attention due 
to their ability to accumulate high intracellular content 
of neutral lipids, which are considered as alternatives 
to plant oils for biodiesel production [1]. Among these 
oleaginous species, Yarrowia lipolytica is a well-studied 
model organism for genetic and physiological research 
as well as for industrial applications [2–5]. The establish-
ment of the genome sequence of Y. lipolytica strain E150 
(CLIB99) [6, 7] and the development of critical genetic 
tools, such as transformation methods [8] and integrative 
expression cassettes [9–12], provide a solid platform 
for metabolic engineering. Compared with Y. lipolytica, 
L. starkeyi has been less well studied due to the lack of 
advanced genetic tools and generally insufficient knowl-
edge of its cellular genetics. However, L. starkeyi is oth-
erwise a very attractive host species, due to its high lipid 
content (~60%) [13] and ability to utilize biomass-derived 
sugars, including glucose, xylose, mannose, and galactose 
[14, 15]. These features make L. starkeyi a unique species 
for developing biofuels. With the very recent develop-
ment of a transformation protocol [16], genetic engineer-
ing now enables L. starkeyi to serve as unique oleaginous 
yeast for further biofuel research.
Current research on oleaginous yeasts for biofuels 
applications has mainly focused on lipid production. 
Increasing lipid content in Y. lipolytica has been widely 
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investigated [12, 17–20]. Lipids are stored intracellu-
larly in a neutral form as triacylglycerol (TAG) and can 
be chemically transesterified to fatty acid methyl and 
ethyl esters (FAME and FAEE), which serve as biodies-
els. Although TAGs are valuable renewable precursors 
for biodiesel production, they are not directly compat-
ible with existing fuels. In addition, lipid extraction using 
solvent and upgrading are costly processes. We have, 
therefore, begun to investigate secreted fatty acid-derived 
products which can be easily recovered and further 
upgraded to fuels. Among the fatty acid-derived prod-
ucts in oleaginous yeasts, fatty alcohol is another valuable 
product having many applications, including detergents 
and cosmetics. Currently, fatty alcohols are primarily 
petroleum derived or derived from plants’ oils or animal 
fats [21, 22] and can be easily upgraded via hydrodeoxi-
genation processes. Fatty alcohols can also be biologically 
produced from fatty acyl-CoA by NAD(P)H-dependent 
fatty acyl-CoA reductase and are generating interest as a 
renewable biofuel. Microbial production of fatty alcohol 
was first reported in Escherichia coli and Saccharomyces 
cerevisiae by introducing a fatty acyl-CoA reductase (far) 
gene into the host [23–27]. In E. coli, fatty acid biosynthe-
sis generates acyl–acyl carrier proteins (acyl-ACP) which 
is subsequently converted to fatty acid by thioesterase, 
then to fatty acyl-CoA by acyl-CoA ligase, and finally to 
fatty alcohols by FAR. Expressing acr1 from Acinetobac-
ter calcoaceticus along with expression of tesA and fadD 
in E. coli resulted in production of medium chain length 
fatty alcohols of 60 mg/L [25]. When tesA and fadD were 
co-expressed with the far gene, Maqu_2220, from Marin-
obactor aquaeolei VT8, the titer of fatty alcohol reached 
422 mg/L in a shake flask and over 1.7 g/L in fed-batch 
fermenter [23]. Very recently, a novel strategy consisting 
of enhancing the acyl-CoA pool with expression of an 
orthogonal type I fatty acid synthase in conjunction with 
tesA, fadD and the far gene (Maqu_2220 from M. aquae-
olei), significantly enhanced the fatty alcohol production 
in E. coli, achieving a titer of 3.5 g/L [28]. Type I fatty acid 
synthesis system commonly found in mammals and fungi 
can be advantageous for fatty alcohol synthesis since it 
releases fatty acyl-CoA directly which can be used as sub-
strate for FAR. However, despite of this advantage, the 
fatty alcohol titers in the engineered S. cerevisiae, which 
co-expressed the far gene, the fatty acid synthesis path-
way genes as well as the regulatory genes in lipid metabo-
lism, were relative low, i.e., 93.4 mg/L [24] for the mouse 
far gene expression, 84 mg/L for the bird far gene expres-
sion [29] and 330 mg/L for barn owl far gene expression 
in shake flasks [30]. In a recent report, expressing barn 
owl far gene in Y. lipolytica together with dga1 and fao1 
knock out led to production of 636.89  mg/L intracellu-
lar and 53.32  mg/L extracellular fatty alcohols [31]. In 
contrast to the low lipid content in Y. lipolytica, some 
oleaginous yeasts are capable of accumulating up to 60% 
of lipid intracellularly, which implicates abundant meta-
bolic flux to fatty acyl-CoA. This strong de novo synthe-
sis of the fatty acid pathway can be attractive for fatty 
alcohol synthesis. Indeed, a very recently report by Fil-
let et al. showed substantially higher production of fatty 
alcohol reaching 800 mg/L from glucose in flask and over 
8 g/L from sucrose in 7 L bioreactors by the oleaginous 
yeast Rhodosporidium toruloides expressing the far gene 
Maqu_2220 [32].
Similarly, as is the case for R. toruloides, L. starkeyi 
might also be a good source for fatty alcohol production 
considering its strong de novo synthesis of fatty acids, 
typically leading to ~60% intracellular neutral lipids. 
Although L. starkeyi has been genetically intractable due 
to lack of genetic tools until recently, a workable trans-
formation method was introduced by Calvey et  al. [16]. 
Compared to Y. lipolytica, for which genetic engineer-
ing techniques have been well established, engineering 
L. starkeyi was more challenging. In the present study, 
we investigated the fatty alcohol production capacity of 
two oleaginous yeasts, Y. lipolytica and L. starkeyi, fol-
lowing transformation with a heterologous far gene. As 
shown in Fig. 1 [33], fatty alcohol production is diverted 
from fatty acyl-CoA instead of going to TAG production . 
We demonstrated that the far gene, Maqu_2220 from 
M. aquaeolei VT8, was successfully expressed in both Y. 




Yarrowia lipolytica Po1g (MatA, leu2-270, ura3-
302:URA3, xpr2-332, and axp-2) and the vector pYLEX1 
were purchased from Yeastern Biotech Co. (Taipei, Tai-
wan). The vector pMT015-YTEFin was constructed by 
replacing the hp4d promoter of pYLEX1 with the trans-
lation elongation factor-1a (TEF) promoter as described 
in the literature [18]. This promoter was synthesized 
(Genscript) as a SalI-KpnI fragment and ligated into the 
appropriately restricted pYLEX1 vector. The gene encod-
ing Maqu_2220, a fatty acyl-CoA reductase (MaFAR) 
from M. aquaeolei VT8 [21 (Accession: YP_959486), was 
codon optimized and synthesized (GenScript). The syn-
thesized gene product was ligated with the SnaBI–NsiI 
double-restricted vector pMT015-YTEFin. This vector 
also contains a leucine selection marker gene (LEU2) to 
complement the deletion of the LEU2 gene in the par-
ent strain of Po1g. The resulting plasmid, pYLEX14, was 
digested with NotI enabling the linearized plasmid to 
integrate at the PBR docking platform established in the 
genome of Y. lipolytica Po1g (YLEX expression kit).
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Lipomyces starkeyi NRRL Y-11557 used in this study 
was obtained from National Center for Agricultural Uti-
lization Research, USDA-ARS, Peoria, IL, USA. Genomic 
DNA was isolated using the Ultraclean Soil DNA Isolation 
Kit (MoBio Laboratories Inc.). To transform L. starkeyi, a 
selection plasmid was constructed using the native TDH3 
promoter (primers listed in Table 1. EK9, EK10) and PGK1 
terminator (EK13, EK14) of L. starkeyi to express the 
NAT1 gene of Streptomyces noursei encoding resistance to 
nourseothricin. The promoter and terminator were PCR-
amplified from genomic DNA having a 5′ and 3′ regions 
homologous to a region of pUC19 just upstream of the 
multicloning site. The SnNAT1 gene (EK11, EK12) was 
PCR-amplified from pYL16 (Werner Bioagents, Germany) 
having 5′ and 3′ regions of homologous overlap with the 
promoter and terminator, respectively, to construct the 
LsTDH3p-MaFAR-LsPGK1t expression cassette. The plas-
mid pUC19 (EK15, EK16) was also PCR-amplified with 
5′ and 3′ regions of homology to the L. starkeyi promoter 
and terminators. The PCR products were gel isolated, 
purified using the Qiaquick Gel Extraction Kit (Qiagen), 
and assembled as a 4-fragment Gibson assembly reaction 
Fig. 1 Biosynthetic pathway of fatty alcohol in Yarrowia lipolytica and Lipomyces starkeyi. The yellow-shaded pathway from fatty acyl-CoA to fatty 
alcohol indicates the engineered steps for the fatty alcohol synthesis described in this work. ACC acetyl-CoA carboxylase; ACL ATP citrate lyase; G3P 
glyceraldehyde 3-phosphate; DGA diacylglycerolacyltransferase; DHAP dihydroxyacetone phosphate; F-6-P fructose 6-phosphate; FAS fatty acid 
synthase; G-6-P glucose 6-phosphate; LPA lysophosphatidic acid; MaFAR fatty acid reductase of Marinobactor aquaeolei VT8; OAA oxaloacetate; PD 
pyruvate dehydrogenase; PL phospholipid; Pyr pyruvate; TAG triacylglycerol. The diagram is based on summary views of lipid biosynthesis in the 
recent literature described in the text of this paper
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(Gibson Assembly Cloning Kit, NEB). This selection vec-
tor was designated pEKLs1 and was PCR-amplified (EK23, 
EK24) for the next construction step. The native PYK1 
promoter (EK17, EK21) and GAL1 terminator (EK18, 
EK22) of L. starkeyi were PCR-amplified from genomic 
DNA having 5′ and 3′ regions of homology to pEKLs1 
upstream of the NAT1 expression cassette The promoter, 
terminator, and pEKLs1 vector PCR products were gel 
isolated and used for a three-fragment Gibson assembly. 
The resulting vector was designated pEKLs2 and allows for 
the insertion of any gene of interest for overexpression in 
L. starkeyi by Gibson assembly between the LsPYK1p and 
LsGAL1t. The gene encoding MaFAR was PCR-amplified 
from pYLEX14 (described above) having 5′ and 3′ regions 
of homology to the LsPYK1p and LsGAL1t. The PCR-
amplified MaFAR gene and pEKLs2 vector (EK17, EK18) 
were gel isolated and used for a two-fragment Gibson 
assembly. Correct insertion of the MaFAR gene was con-
firmed by DNA sequencing, and the resulting plasmid was 
named pLS101-4.
Transformation and selection
Targeted integrative transformation of Y. lipolytica with 
pYLEX14 was conducted as described by Wei et  al. 
[34] using the YLOS One-step Transformation system 
included in the YLEX expression kit. For the selection of 
prototrophic recombinants (Leu+), transformants were 
grown on solid YNB medium (2% glucose w/v, 0.67% 
yeast nitrogen base w/o amino acids, 1.5% agar), incu-
bated at 28 °C for 2–4 days.
Random integrative transformation of L. starkeyi was 
conducted as described by Calvey et al. [16]. A single col-
ony of L. starkeyi was inoculated into YPD medium and 
incubated at 30  °C and shaken at 225  rpm until OD600 
reached 5.2. Cells were harvested by centrifugation at 
3000  rpm for 5  min, washed with 25  mL of water and 
resuspended in 0.5  mL of 0.1  M LiAc. Suspended cells 
(100 µL) were dispensed into a microcenrifuge tubes and 
briefly pulsed to collect the cells and remove the LiAc. 
The collected cells were resuspended in 240  µL of PEG 
(50% w/v, MW 3650), 30 µL of 1 M LiAc, 3 µL of ssDNA 
(10 µg/µL), and linearized DNA and water to equal 27 µL 
(300  µL total volume) and vortexed thoroughly. The 
mixture was incubated at 30  °C for 3 h without shaking 
and then treated under a 5-min thermal shock at 40  °C. 
The cells were pelleted by centrifugation for 15  s, and 
the supernatant was removed. The cell pellet was resus-
pended in one mL of YPD medium and incubated at 
30  °C and 225 rpm for 3 h. Cells were then centrifuged, 
resuspended in 0.5 mL of water, and plated on YPD with 
30  µg/mL of nourseothricin (ClonNAT). Transformants 
appeared after 5  days incubation at 30  °C. The success-
ful transformation and integration of the Maqu_2220 
gene in both Y. lipolytica and L. starkeyi were verified by 
PCR amplification (see Table 1 for primer sequences) of 
a 206 bp fragment internal to the Maqu_2220 gene using 
extracted genomic DNA as a template.
Culturing of far transformants for fatty alcohol production
Cultures of Y. lipolytica and L. starkeyi far transformants 
were grown in 250  mL baffled shake flask. For both 
strains, seed cultures were first prepared in 5 mL of YPD 
broth in 125 mL flasks. For Y. lipolytica, the seed culture 
was incubated at 28 °C and 220 rpm. After 24 h, 2.5 mL 
of seed culture was inoculated into 25  mL of produc-
tion medium in a 250  mL shake flask and incubated in 
a shaker at 28  °C and 220 rpm. For L. starkeyi, the seed 
culture was incubated at 30  °C and 220 rpm. L. starkeyi 
grew slower compared to Yarrowia, thus we harvested 
the seed culture of Lipomyces at 36 h instead of 24 h. The 
production medium inoculated with the seed culture 
was cultivated at 30 °C and 220 rpm. For the culture with 
dodecane overlay, 3  mL of dodecane was added to the 
production medium, 48 h after the cultivation in 250-mL 
flask was started. For the analysis of fatty alcohol produc-
tion, cultures were harvested at 5 days unless otherwise 
stated and centrifuged at 4000 rpm. The cell pellet, super-
natant and dodecane phase (if overlaid with dodecane) 
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were separated after centrifugation. Flask experiments 
were run in triplicates, the data were shown as the aver-
age of the triplicates, and error bars represent the stand-
ard deviation of the triplicates.
The medium used for fatty alcohol production in this 
study was mineral medium containing (g/L): (NH4)2SO4, 
0.5; KH2PO4, 7.0; Na2HPO4, 2.0; MgSO4·7H2O, 1.5; 
CaCl2·2H2O, 0.1; FeCl3·6H2O, 0.08; ZnSO4·7H2O, 0.001; 
CuSO4·5H2O, 0.0001; CoCL2·H2O, 0.0001; MnSO4· 
5H2O, 0.0001 and vitamin supplements. The carbon 
source was glucose (3% w/v). The initial pH value of the 
medium was pH 6.0. For culturing of the control strain 
of Y. lipolytica Po1g in mineral medium, leucine was sup-
plemented to the medium at a concentration of 0.1 g/L.
GC–MS analysis for fatty alcohols
Fatty alcohols were extracted from media, cell pellets, 
and whole culture (media +  pellet) using an extraction 
procedure similar to Steen et al. [25] for analysis (except 
for the culture with dodecane overlay where samples of 
dodecane phase were directly used for GC–MS analysis). 
In brief, 10 μL of a recovery standard consisting of 5 mg/
mL tridecanol in ethyl acetate was spiked into 10  mL 
of sample and vortexed thoroughly. Spiked samples 
were extracted with 40% (v/v) ethyl acetate. To facilitate 
extraction, samples were hand shaken for 2  min before 
centrifugation at 4  °C for 10  min at 3000  rpm. A blank 
sample consisting of 10 mL of water spiked with recov-
ery standard was also run with each extraction set. If the 
two phases formed an emulsion, samples were placed in 
a freezer (0  °C) overnight before continuing. The ethyl 
acetate phase was recovered and dried down under a 
steady stream of N2 to a little less than 1 mL before being 
quantitatively transferred to a glass GC vial, and finally 
brought to a 1 mL total volume.
Analysis for fatty alcohols was performed on a 7890N 
Agilent GC system with an Agilent DB-Wax column, 
30  m ×  0.25  mm ×  0.25  μm. The GC parameters used 
were as follows: 1  μL injection, split ratio 10:1, injector 
temp 250  °C, constant flow 1  mL/min He; oven ramp 
100 °C for 1 min, 25 °C/min to 200 °C and hold for 1 min, 
5  °C/min to 250  °C and hold for 7 min; FID detector at 
280 °C, 40 mL/min H2, 450 mL/min zero air, 30 mL/min 
makeup He, collection at 5  Hz. Saturated and unsatu-
rated fatty alcohols were quantified using two fatty alco-
hol standards (NuChek GLC 32C and 34C). A similar 
program was run on the GC–MS to verify peak identities.
Where applicable, samples were overlain with 10% 
(v/v) dodecane during growth. The dodecane layer was 
recovered and diluted as necessary before being run on 
the GC-FID as described above. All the samples were 
analyzed in triplicates, and the standard deviations 
were <0.35%.
Lipid determination
The cell biomass was harvested by centrifugation and 
freeze dried for lipid determination. 0.2 mL chloroform–
methanol (2:1 v/v) was added to 7–11 mg of lyophilized 
biomass to solubilize the lipids and simultaneously trans-
esterify the lipids in situ with 0.3 mL HCl–methanol (95% 
v/v) for 1 h at 85 °C. The resulting FAMEs were extracted 
with 1 mL hexane at room temperature for 1 h and ana-
lyzed by gas chromatography GC-FID (Agilent 6890N) 
using DB5-MS column (Agilent, USA). Quantification of 
the FAMEs was based on integration of individual fatty 
acid peaks in the chromatograms and quantified using a 
5-point calibration curve of a mixed, even carbon chain 
FAME standard of 14 individual fatty acids (C8–C24, 
SIGMA cat# 18918). The total lipid content was calcu-
lated as the sum of the even numbered FAMEs contribu-
tions. All the samples were analyzed in triplicates, and 
the standard deviations were <0.35%.
Results and discussion
Production of fatty alcohols in far‑expressing Y. lipolytica 
Yl[FAR]
A well-known and commercially available YLEX expres-
sion kit was used for Y. lipolytica transformation. 
The successful transformation and integration of the 
Maqu_2220 gene in Y. lipolytica was verified by PCR 
amplification as described in ’’Methods’’ section. Due to 
the targeted integration at a specific docking site in Y. 
lipolytica, effects on expression due to random integra-
tion localization are not expected. Three far transfor-
mants were cultured and characterized in terms of cell 
growth and fatty alcohol production, and they turned 
to show very similar growth and fatty alcohol produc-
tion profile. Thus only one transformant was chosen for 
further study. Expression of the far gene in Y. lipolytica 
did not impact cell growth (Fig.  2a) and resulted in the 
production of up to 167  mg/L of fatty alcohols in min-
eral medium while the control Y. lipolytica Po1g did not 
produce any fatty alcohols. This titer was approximately 
three times higher than that observed with the single 
mouse mfar1 gene expression in S. cerevisiae (56.5 mg/L) 
[24] and six times higher than the bird far gene expres-
sion in S. cerevisiae (26 mg/L) [29]. Analyzing the cell pel-
lets and supernatant separately showed that 97% of the 
produced fatty alcohol was associated with or trapped in 
the cells while only 3% was secreted (Table 2). This result 
is consistent with the recent research about Y. lipolytica 
that most of the fatty alcohols were retained intracellu-
larly when TaFAR1 gene was expressed in Y. lipolytica 
[31]. Using a 10% (v/v) dodecane overlay during growth, 
92.5% of the produced fatty alcohols were extracted into 
the dodecane phase, while only 5% remained associated 
with cells (Table  2). This high extraction efficiency by 
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dodecane would undoubtedly benefit downstream sepa-
ration processes. 
In this study, we also compared fatty alcohols produc-
tion titers with and without dodecane overlays during the 
incubation. Our characterizations show that 14% more 
fatty alcohols were detected in dodecane-overlaid cul-
tures than without dodecane overlays (Fig. 2b). This may 
be due to the inhibition or toxicity of fatty alcohols to the 
cells in non dodecane-overlaid cultures. We also found 
differences in the concentrations of fatty alcohols between 
the whole culture analysis and the pellet plus supernatant 
determined separately. For example, for the same culture, 
we found 21% less fatty alcohols from the whole culture 
analysis compared to the separate analysis of cells and 
supernatant (Table  3). This lower value in the measured 
fatty alcohol titer by the whole culture analysis method 
could be due to a lower extraction efficiency when cells 
and medium were mixed together. Overlaying dodecane 
appears to be the most efficient method to recover the 
produced fatty alcohols, thus in the following experi-
ments, we overlaid dodecane on all the culture broths, 
and fatty alcohols in dodecane phase were measured.
Lipid accumulation and fatty alcohol composition 
in Yl[FAR]
Overexpressing the far gene in Y. lipolytica led to 15% 
decrease in lipid content (7.9  ±  0.1% compared to the 
parent strain 9.3  ±  0.3%), indicating that the carbon 
flux originally going to TAG synthesis might partially 
be redirected toward fatty alcohol production. Note that 
the lipid composition profile in the far transformant was 
identical to that of the parent strain Y. lipolytica Po1g, 
and the lipid profile of the parent strain is consistent with 
the previous studies [18], i.e., C16:0 and C18:1 are two 
major fatty acids species (see Fig. 3a).
The composition of the fatty alcohols produced in 
Yl[FAR] is shown in Fig.  3b. The fatty alcohols with a 
long chain length, i.e., hexadecanol (C16:0), octadecan-
ols (C18:0), and (C18:1) accounted for 53.1, 36.3, and 
10.4%, respectively, of the total alcohols. It is noteworthy 
that saturated fatty alcohols were predominant in all the 
produced fatty alcohols, which could be beneficial for 
downstream upgrading to hydrocarbons as less hydrogen 
is needed in the hydrotreating process. The fatty alcohol 





































Fig. 2 Cell growth (a) and fatty alcohols production (b) by far-expressing Y. lipolytica growing on mineral medium. The control represents empty 
vector control
Table 2 Fatty alcohols distribution in Y. lipolytica fermentation broth samples with and without dodecane overlay
Sample Sample  
volume (ml)
Fatty alcohols  
in dodecane (mg)
Fatty alcohols in  
supernatant (mg)




Without dodecane 55.0 N/A 0.24 ± 0.04 7.78 ± 0.10 8.02 ± 0.10
With dodecane 55.0 8.52 ± 0.02 0.23 ± 0.02 0.46 ± 0.02 9.21 ± 0.05
Table 3 Fatty alcohols in  L. starkeyi fractions: analyzing 













140.8 ± 2.5 4.2 ± 0.2 145.0 ± 2.2
Whole culture N/A N/A 115.0 ± 5.0
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is very similar to the recently published research on fatty 
alcohol production in Y. lipolytica, although a different 
source of far gene was expressed. Does this indicate that 
fatty alcohol composition is species specific? More cases 
of studies on different far gene expressions in Y. lipolytica 
will help to answer this question.
Production of fatty alcohols in far‑expressing L. starkeyi 
Ls[FAR]
Oleaginous yeasts require fatty acyl-CoA for de novo 
biosynthesis of TAG. Fatty acyl-CoA is a central inter-
mediate in fatty acid synthesis which can be converted 
to various fatty acid-derived products including TAG 
and fatty alcohols via different enzymes. Overexpress-
ing the far gene in oleaginous yeast is a straight forward 
strategy to bypass the TAG synthesis pathway by pulling 
fatty acids (in fatty acyl-CoA form) toward fatty alcohols 
production. The lipid content in the parent strain Y. lipo-
lytica Po1g, used in this study, was less than 15% percent, 
whereas lipid content in L. starkeyi was greater than 
50%. As L. starkeyi accumulates higher levels of TAG, we 
assume higher levels of fatty acyl-CoA are produced as an 
intermediate in L. starkeyi than in Y. lipolytica. Therefore, 
more fatty acyl-CoA should be available for conversion to 
fatty alcohols when overexpressing the far gene. To this 
end, the same MaFAR gene was also expressed in L. star-
keyi NRRL Y-11557.
The successful transformation and integration of the 
Maqu_2220 gene in L. starkeyi was verified by PCR 
amplification as described in ’’Methods’’ section. Due to 
the nature of random integration and the possibility of 
effects on gene expression due to integration localiza-
tion, 20 transformants with random insertions of the far 
gene were chosen for characterization. All the transfor-
mants were confirmed to produce fatty alcohols, albeit 
at varied titers (Fig.  4). Considering the random inser-
tion of far gene, this variation in fatty alcohols produc-
tion among the transformants is not unexpected and 
could be due to different copy numbers or locations of 
the inserted far gene in the genome. Further work will 
be done to understand the mechanism involved. Among 
the 20 transformants found, transformants 6 and 10 pro-
duced more fatty alcohols than the others in mineral 
medium, 720 and 770  mg/L after 5 days, respectively. 
This production titer is comparable to the same far gene 
expression in R. toruloides grown on glucose medium. 
The higher level of fatty alcohol production may be 
related to the robust fatty acid synthesis in L. starkeyi as 
indicated by high lipid content in wild type cells. More-
over, the level of the fatty alcohols produced in L. star-
keyi from mineral medium containing 3% glucose is very 
comparable to the fatty alcohol production by another 
high lipid-accumulating oleaginous yeast R. toruloides, 
0.8  g/L fatty alcohols produced from YP medium con-
taining 4% glucose [32].
Lipid accumulation and fatty alcohol composition 
in far‑expressing Lipomyces Ls[FAR]
The FAME composition data of the wild type L. starkeyi 
in our study were consistent with the previous studies 
on this strain, i.e., C16:0 and C18:1 fatty acids were pre-
dominant [13]. Similar to Y. lipolytica, expression of the 
far gene in L. starkeyi also led to a decrease in lipid con-
tent while lipid composition profiles remained the same 
as the parental control (Fig. 5). Considering transformant 
10, for example, FAME content was found to decrease to 
40.6% at 5 days, compared to 56.9% in the control.
Although fatty alcohols were produced by expressing 
the far gene in L. starkeyi, we found that there remained 






















































































































Fig. 3 Lipid and fatty alcohol compositions in Yl[FAR] growing on mineral medium at 5 days. Fermentation medium was overlaid with dodecane.  
a Lipid composition. b Fatty alcohol composition. The control represents empty vector control
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though we tried to bypass the TAG synthesis pathway 
by redirecting carbon flux to fatty alcohols production. 
A much stronger “pull” enhancing MaFAR expression is 
needed. In addition to the “pull” strategy, blocking TAG 
synthesis, i.e., disruption of the dga gene which encodes 
for diacylglycerol acyltransferase, the final enzyme for 
TAG synthesis, is another strategy for further enhancing 
fatty alcohol production. Also, as demonstrated in recent 
research [31], eliminating fatty alcohol degradation path-
way, might be another strategy deserving a try. However, 
considering the complex nature of this species and for 
other unknown genetic reasons, the subsequent knock-
ing out genes is very challenging. To this end, a more effi-
cient transformation system able to achieve targeted gene 
knock-out must be developed.
The patterns of fatty alcohols composition in L. starkeyi 
far transformants were similar to that of Y. lipolytica. In 
all the far transformants, long chain fatty alcohols i.e., 
saturated hexadecanol (C16:0) and octadecanol (C18:0) 
accounted for 85–88% of the total fatty alcohols, whereas 
unsaturated octadecanol (C18:1) accounted for 12–15%. 
This result is in contrast to the fatty alcohols composi-
tion in R. toruloides, which showed a very high content of 
unsaturated oleyl alcohol (C18:1, 69%) and low contents 
of saturated hexadecanol (C16:0) and octadecanol (C18:0) 
(12% and 19%, respectively) [32]. In transformants 6 and 
10, the two far transformants with the highest fatty alco-
hols titers, a small fraction (about 2.5%) of long chain fatty 
alcohol (C20:0) was also observed (Fig. 6).
The fatty alcohols profiles in Y. lipolytica and L. starkeyi 
are pretty similar showing that saturated C16:0 and C18:0 
fatty alcohols predominate, accounting for 85–90% of 



























Fig. 4 Fatty alcohol production by far-expressing L. starkeyi transformants on mineral medium at 5 days. Fermentation medium was overlaid with 

















Fig. 5 Lipid compositions in Ls[FAR] transformant 10 growing on 
mineral medium at 5 days. The standard deviation of triplicates 





















Fig. 6 Fatty alcohol compositions in Ls[FAR] transformants 6 and 10 
growing on mineral medium at 5 days
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from the composition profiles of R. toruloides and E. coli 
ever reported, although the same MaFAR was expressed 
[23, 32]. In R. toruloides, unsaturated oleyl alcohol 
(C18:1) was predominant, accounting for 57% of the total 
fatty alcohols [32]. In E. coli, C16:0 and C18:1 were major 
components, but about 15% of shorter chain length C12:0 
and C14:0 fatty alcohols also existed [23]. This indicates 
that the far gene Maqu_2220 has broad substrate speci-
ficity. The difference in composition profile for the same 
far gene in different strains might be related to different 
growth medium and culturing conditions. Carbon chain 
lengths and degrees of saturation affect the physiochemi-
cal properties of fatty alcohols enabling different applica-
tions. By expressing different far genes and optimizing 
medium and fermentation conditions (e.g., different car-
bon sources), the carbon chain length of fatty alcohols 
may be tailored according to different substrate specifi-
cities of various far genes, and this could be explored in 
future work.
Fatty alcohol production with glucose and xylose 
as substrate
An important characteristic of L. starkeyi is that it can 
utilize both glucose and xylose. The profile of fatty alcohol 
production by transformant 10 with glucose as substrate 
is depicted in Fig. 7a. Cell growth reached the stationary 
phase around 72 h even though the sugars were not com-
pletely consumed. The limited nitrogen content (0.5 g/L) 
for these cultures likely lead to a cessation of cell growth 
while still allowing fatty alcohol production. Lipid accu-
mulation reached 40% within 72 h and slowly decreased 
thereafter, although glucose was still being consumed by 
the strain. It is noteworthy that fatty alcohols production 
increased as cultivation continued, reaching 735  mg/L 
at 144 h. At an extended fermentation, the fatty alcohols 
titer could reach up to about 800  mg/L at 192  h. After 
72 h, it appears that the glucose consumption did not fur-
ther contribute to cell growth or lipid synthesis, but fatty 
alcohols production continued at the same rate. Interest-
ingly, once the glucose were exhausted at 120 h, the pro-
duction of fatty alcohols continued but at a slower rate. 
This could be due to continued metabolic activity (e.g., 
de novo fatty alcohol production) or continued secre-
tion of fatty alcohols that had built up inside of the cell 
previously. Clearly further experiments are warranted 
to understand the timing and rates of intracellular fatty 
alcohol production. Also of interest is the rapid use of 
xylose by L. starkeyi. Typically glucose is the preferred 
carbon source of any given organism, however L. starkeyi 
can utilize xylose as well as glucose.
The profile of fatty alcohol production by transfor-
mant 10 with xylose as substrate is similar to that using 
glucose as substrate, except that cell mass and the fatty 
alcohol titer were slightly lower on xylose than that on 
glucose (Fig. 7b). It was found that 587 mg/L fatty alco-
hols were produced at 144 h. With an extended incuba-
tion, the fatty alcohols titer could reach up to 710 mg/L 
at 192 h. We noted that the rate of xylose utilization is as 
fast as that of glucose, which is advantageous for utilizing 
biomass-derived sugars as feedstocks. The ability of L. 
starkeyi capable of producing high level of fatty alcohols 
from xylose makes it very attractive to use lignocellulosic 
biomass feedstocks. Although R. toruloides was shown to 
produce fatty alcohol from mixture of glucose and xylose, 
the levels are very low (220 mg/L); However, the rate of 
the fatty alcohol production in L. starkeyi is rather slow 
as compared to R. toruloides. [32].
The yields of fatty alcohols growing on glucose or xylose 
are summarized in Table 4. From these data, we note that 









































































































Fig. 7 Cell growth, fatty alcohols, and lipid production by Ls[FAR] transformant 10 on mineral medium. a Glucose as substrate. b Xylose as substrate
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fatty alcohol synthesis pathway might be rate-limiting. 
Engineering other genes in fatty acid synthesis pathway, 
i.e., knocking out genes leading to TAG synthesis or over-
expressing genes leading to more accumulation of fatty 
acyl-CoA might help to achieve high fatty alcohol titers.
During fermentations on glucose and xylose, the pat-
terns of fatty alcohol composition changing with time 
were similar (Fig. 8). At early stage, i.e., 24 h, C18:0 fatty 
alcohol was preferentially produced. After 72 h, the per-
centage of C16:0 fatty alcohol increased, while C18:0 
fatty alcohols dropped. In contrast, the percentage of 
C18:1 fatty alcohol remained nearly constant through-
out the fermentation. It is noteworthy that, regardless 
of the change in the ratios of C16:0 and C18:0 fatty alco-
hols, the amounts of C16 and C18 fatty alcohols together 
accounted for about 85–90% of total fatty alcohols 
throughout the cultivation process.
Distribution of fatty alcohols produced by far‑expressing 
L. starkeyi
The distributions of the fatty alcohols produced by far-
expressing Y. lipolytica and L. starkeyi were quite dif-
ferent. In Y. lipolytica, only 3% of the total was secreted, 
while in L. starkeyi, more fatty alcohols, at least 50% of 
the total was secreted from the cells into the medium. 
The partition of fatty alcohols in L. starkeyi is similar to 
that in far-expressing R. toruloides where 80% of fatty 
alcohols were secreted into culturing broth [32]. In the 
beginning, this striking difference in secretion led us 
think that there might be a threshold for fatty alcohols 
to secrete out instead of retaining intracellularly because 
the fatty alcohol titers in L. starkeyi and R. toruloides 
were much higher compared to that in Y. lipolytica. How-
ever, we got the same partition profile in low fatty alco-
hol producing L. starkeyi transformants (~200 mg/L fatty 
alcohols), i.e., more than half of the total fatty alcohols 
were secreted into the broth. This difference in fatty alco-
hol secretion titers for these strains could be related to 
the different permeabilities of cell membranes. Therefore, 
a structural and compositional analysis of the cell mem-
branes might help elucidate the mechanism underlying 
the partition phenomena. Undoubtedly, the secretion of 
fatty alcohols could be beneficial for downstream prod-
uct processing (e.g., separations), as well as for cell viabil-
ity, considering the potential for fatty alcohols to be toxic.
Conclusions
In summary, this study demonstrates fatty alcohol produc-
tion by the oleaginous yeast, Y. lipolytica and L. starkeyi. 
By expressing the far gene from M. aquaeolei VT8 in both 
strains, 167 and 770  mg/L fatty alcohols were generated 
by Y. lipolytica and L. starkeyi growing on glucose, respec-
tively. Furthermore, Y. lipolytica has been considered a 
model strain for the study of fatty acid synthesis in recent 
Table 4 Yields of fatty alcohols on glucose or xylose as substrate (g/g glucose or xylose)
Time (h)
0 24 48 72 96 120 144 192
Yield on glucose (g/g) 0.00 0.01 0.01 0.01 0.02 0.02 0.02 0.03












































Fig. 8 Pattern of fatty alcohol composition during fatty alcohol production process. a Glucose as substrate. b Xylose as substrate
Page 11 of 12Wang et al. Biotechnol Biofuels  (2016) 9:227 
years. Our work demonstrates that, in addition to Y. lipol-
ytica, L. starkeyi can also serve as a platform organism for 
production of fatty acid-derived biofuels and bioproducts 
via metabolic engineering. Our results show that L. star-
keyi far gene transformant was able to produce fatty alco-
hols from both glucose and xylose, providing a basis for 
further engineering aimed at increasing fatty alcohol titer 
on cellulosic biomass feedstocks. To this end, more strat-
egies are needed to enhance the fatty alcohol production, 
e.g., increase the copy number of the far gene. We believe 
that strain and process development can be combined to 
significantly contribute to the goal of producing scalable 
and cost-effective fatty alcohols from renewable biomass.
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